WCN26-5007 STEROID TOXICITY IN CHILDREN WITH IgA NEPHROPATHY: WAS IT WORTH THE WEIGHT?

Read full text Summarise with VIRAT
Authors: Areefa Alladin, Susan M. Samuel, Andrew Wade, Pietro Ravani, Kathryn A. Birnie, Ngan N. Lam, Robert Ross Quinn
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

IgA nephropathy (IgAN) is a rare condition with limited randomized controlled trials in children. As a result, treatment in children primarily relies on adult data. Historically, children were treated with the Pozzi Protocol (4-6 months of glucocorticoids [steroids]) based on an adult study (1999). However, applying adult data to children is not ideal because pharmacokinetics and pharmacodynamics may influence how children respond. Additionally, children are vulnerable to adverse drug events (ADEs) from steroids, especially during puberty.

Fields of Study & Subjects

Renal Diseases and Glomerulopathies Renal Transplantation Outcomes and Treatments Vasculitis and related conditions

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
106234–106234
Publication date
25 March 2026
Language
EN